New drug delivery tech aims to target glioblastoma and severe skin diseases directly. £1 million Sheffield project uses Cold Atmospheric Plasma and molecular imprinting. Molecularly Imprinted Polymers grow hydrogels around drugs for precise, on-demand release.
